PXD067801 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Novel peptides from the edible bivalve Ruditapes decussatus target apoptosis, autophagy, and FGF19-FGFR4 signaling in human cancer cell lines |
| Description | Bioactive peptides have recently emerged as promising candidates for cancer treatment due to their selective cytotoxicity toward cancer cells. The bivalve mollusk Ruditapes decussatus contains bioactive compounds that have not been thoroughly investigated for their potential anticancer properties. In this study, isolation and purification of peptide mixtures from R. decussatus was performed using FPLC chromatography followed by de novo sequence analysis. Using de novo peptide sequencing, a total of 135 peptides (ranging from 2,681.6 to 5,925.12 Da) were identified, of which 57 peptides (42%) were predicted to exhibit anticancer potential upon analysis with AntiCP 2.0, highlighting their possible therapeutic utility. Additionally, fractions were tested against liver (HepG2) and colorectal (HT-29) cancer cell lines, as well as normal human hepatocytes and VERO (obtained from kidney) cells, to evaluate their cytotoxic effects. Fractions 2 and 3 showed significant anticancer activity against both cancer cell lines, while exhibiting minimal cytotoxicity toward normal cells. These fractions induced apoptosis, as evidenced by the downregulation of Bcl-2 and upregulation of caspase-3, and also activated autophagy, marked by increased Beclin-1 expression. Flow cytometry analysis revealed enhanced apoptotic cell death and G1/S phase cell cycle arrest in the treated cancer cells. Morphological analysis further confirmed the presence of apoptotic changes. Overall, the peptides derived from R. decussatus demonstrated the ability to induce apoptosis and cell cycle arrest in cancer cells, with a highly selective effect on colorectal carcinoma, suggesting their potential as anticancer agents for further investigation. |
| HostingRepository | PRIDE |
| AnnounceDate | 2025-10-06 |
| AnnouncementXML | Submission_2025-10-05_16:05:32.716.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Ahmed Hussein |
| SpeciesList | scientific name: Ruditapes decussatus; NCBI TaxID: NEWT:104385; |
| ModificationList | iodoacetamide derivatized residue |
| Instrument | Q Exactive |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2025-08-27 09:33:28 | ID requested | |
| ⏵ 1 | 2025-10-05 16:05:33 | announced | |
Publication List
| 10.1038/s41598-025-20094-7; |
| Hussein AAA, Salem MB, ElZallat M, Ghoname SI, Habib MR, Hammam OA, El-Dabaa E, Okasha H, Novel peptides from the edible bivalve Ruditapes decussatus target apoptosis, autophagy, and FGF19-FGFR4 signaling in human cancer cell lines. Sci Rep, 15(1):34283(2025) [pubmed] |
Keyword List
| submitter keyword: Bioactive peptides, Natural agents, Anticancer activity, Mass spectrometry,Bivalves |
Contact List
| Ahmed Hussein |
| contact affiliation | Medical Malacology, Theodore Bilharz Research Institute, Giza, Egypt |
| contact email | ahmed.abdelazeez@science.suez.edu.eg |
| lab head | |
| Ahmed Hussein |
| contact affiliation | Mdical Malacology Department, Theodor Bilharz Research Institute (TBRI) |
| contact email | ahmed.abdelazeez@science.suez.edu.eg |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/10/PXD067801 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD067801
- Label: PRIDE project
- Name: Novel peptides from the edible bivalve Ruditapes decussatus target apoptosis, autophagy, and FGF19-FGFR4 signaling in human cancer cell lines